yipf3 Antibody

What is YIPF3 and why is it significant for research?

YIPF3 (Yip1 Domain Family Member 3) is a 350 amino acid multi-pass membrane protein belonging to the YIP1 family. It plays crucial roles in membrane trafficking and vesicle biogenesis through interactions with Rab GTPases. Recent research has revealed YIPF3's significant function as part of the YIPF3-YIPF4 complex that serves as a receptor for Golgiphagy (selective autophagy of the Golgi apparatus). This makes YIPF3 particularly important for studying organelle quality control mechanisms, membrane dynamics, and cellular stress responses. The protein is expressed in fetal liver and nucleated hematopoietic cells, suggesting developmental roles in hematopoiesis. YIPF3's gene is located on human chromosome 6, a region associated with various health conditions including early onset intestinal cancer and several genetic disorders, highlighting its potential relevance to disease mechanisms .

What types of YIPF3 antibodies are available for research applications?

Several types of YIPF3 antibodies are available for research, including both monoclonal and polyclonal options with various detection capabilities. Mouse monoclonal IgM antibodies (such as E-6) can detect YIPF3 from multiple species including human, mouse, and rat origins. These are suitable for western blotting, immunoprecipitation, immunofluorescence, and ELISA applications. Polyclonal rabbit antibodies targeting different epitopes (such as AA 2-148 or AA 292-321 regions) are also available with various conjugations including unconjugated forms, as well as HRP, FITC, Biotin, and APC conjugates for different experimental needs . This variety allows researchers to select antibodies specific to their experimental design, target species, and visualization requirements.

How do YIPF3 antibodies help in studying Golgi-associated autophagy processes?

YIPF3 antibodies are instrumental in investigating Golgiphagy, as YIPF3 (along with YIPF4) functions as a key receptor for this process. These antibodies enable researchers to visualize YIPF3's localization within the Golgi apparatus under normal conditions and its redistribution during autophagy induction. Immunofluorescence techniques using YIPF3 antibodies allow for the observation of YIPF3-positive puncta that colocalize with autophagosome markers like LC3 (approximately 63.8% colocalization) and lysosomal markers like LAMP1 during starvation conditions . By using YIPF3 antibodies in combination with Golgi markers (GM130, TMEM165, MAN2A1), researchers can track Golgi fragments targeted for autophagic degradation. Additionally, immunoprecipitation with YIPF3 antibodies helps identify YIPF3's interactions with ATG8 family proteins (LC3B, GABARAP, GABARAPL1) through its N-terminal LIR motif, providing mechanistic insights into how the Golgi is recognized and sequestered by the autophagy machinery .

How should YIPF3 antibodies be optimized for Western blotting applications?

For optimal Western blotting results with YIPF3 antibodies, researchers should employ a systematic approach to antibody dilution optimization. Start with a dilution range of 1:500-1:5000 as recommended for polyclonal antibodies targeting YIPF3 . The exact dilution will depend on the specific antibody, sample type, and detection system. YIPF3 is a membrane protein, so sample preparation requires careful consideration—use appropriate lysis buffers containing detergents (such as RIPA buffer with protease inhibitors) to effectively solubilize the protein. Ensure complete denaturation by heating samples with reducing agents before loading. For detection, secondary antibodies should be selected based on the primary antibody host species (mouse for monoclonal E-6, rabbit for polyclonal antibodies). When analyzing results, YIPF3 appears at approximately 38-40 kDa, though post-translational modifications may affect migration patterns. Additionally, consider probing for YIPF4 (approximately 27 kDa) in the same samples to investigate the YIPF3-YIPF4 complex formation, as YIPF4 deletion suppresses YIPF3 levels .

What are the recommended protocols for immunofluorescence studies of YIPF3 and Golgi dynamics?

For immunofluorescence studies of YIPF3 and Golgi dynamics, begin with cell fixation using 4% paraformaldehyde (10-15 minutes at room temperature) followed by permeabilization with 0.1-0.2% Triton X-100. Use a dilution range of 1:50-1:200 for YIPF3 antibodies . To comprehensively study Golgi dynamics and Golgiphagy, implement a co-staining approach using antibodies against YIPF3 together with established Golgi markers such as GM130 (cis-Golgi), TMEM165, or MAN2A1 (medial/trans-Golgi). For autophagy studies, include co-staining with LC3 and LAMP1 antibodies to visualize autophagosomes and lysosomes, respectively. Starvation-induced autophagy can be triggered by incubating cells in EBSS or HBSS for 2-4 hours, with or without Bafilomycin A1 (100-200 nM) to prevent lysosomal degradation and enhance visualization of autophagy structures. Use confocal microscopy with Z-stack imaging to precisely assess colocalization. For quantitative analysis, measure colocalization coefficients and count YIPF3-positive puncta that colocalize with Golgi, autophagosome, and lysosome markers under different conditions .

How can YIPF3 antibodies be used to investigate protein-protein interactions in autophagy pathways?

YIPF3 antibodies can be effectively employed in multiple complementary approaches to investigate protein-protein interactions in autophagy pathways. For co-immunoprecipitation assays, use YIPF3 antibodies to pull down endogenous YIPF3 complexes, followed by immunoblotting for ATG8 family proteins (LC3B, GABARAP, GABARAPL1) to assess direct interactions. Conversely, tagged versions of ATG8 proteins can be used to pull down YIPF3, confirming bidirectional interaction . For studying the YIPF3-YIPF4 complex, perform reciprocal co-immunoprecipitation assays using both YIPF3 and YIPF4 antibodies. Proximity ligation assays (PLA) offer an alternative approach to visualize YIPF3 interactions with autophagy proteins in situ with high sensitivity. For functional validation of interactions, introduce mutations in the LIR motif (particularly F47A, M50A in the first LIR motif) of YIPF3 and assess changes in binding to ATG8 proteins using YIPF3 antibodies . Additionally, split-GFP or FRET-based approaches can be combined with immunostaining using YIPF3 antibodies to visualize dynamic interactions in living cells during autophagy induction.

How can YIPF3 antibodies help investigate the role of LIR motifs in selective autophagy mechanisms?

YIPF3 antibodies provide valuable tools for investigating LIR (LC3-interacting region) motif function in selective autophagy. YIPF3 contains three evolutionarily conserved putative LIR motifs in its N-terminal cytosolic region, with amino acid residues 47-50 (F47-M50) constituting the primary functional LIR motif . Researchers can conduct site-directed mutagenesis studies (creating F47A, M50A mutations) and use YIPF3 antibodies in co-immunoprecipitation assays to determine how these mutations affect interactions with different ATG8 family proteins. Immunofluorescence with YIPF3 antibodies can reveal how LIR mutations alter YIPF3's subcellular localization during autophagy induction. For structure-function analyses, YIPF3 antibodies can be used alongside phospho-specific antibodies to investigate how phosphorylation sites upstream of the LIR motif modulate ATG8 binding, similar to regulation observed in the ER-phagy receptor TEX264 . Comparative studies using YIPF3 antibodies can help establish similarities and differences between LIR-dependent mechanisms across various selective autophagy pathways (mitophagy, pexophagy, ER-phagy, and Golgiphagy), contributing to a unified understanding of organelle-specific autophagy receptor mechanisms.

What approaches can be used with YIPF3 antibodies to quantitatively assess Golgiphagy flux?

Quantitative assessment of Golgiphagy flux using YIPF3 antibodies can be achieved through several complementary approaches. One sophisticated method involves the mRFP-EGFP tandem fluorescent tag system developed specifically for Golgiphagy. This reporter system exploits the acid-sensitive nature of EGFP and acid-resistant properties of mRFP, allowing for discrimination between Golgi fragments in autophagosomes (yellow signal) versus those in autolysosomes (red-only signal). Immunostaining for endogenous YIPF3 in cells expressing this reporter system enables correlation between YIPF3 levels/localization and Golgiphagy progression . Another approach utilizes the Halo tag processing assay, where Halo-mGFP-YIPF3 constructs are expressed and the cleavage of free Halo tag by lysosomal proteases is quantified as a measure of YIPF3 degradation through autophagy . For endogenous protein analysis, YIPF3 antibodies can be used in western blotting to measure YIPF3 protein levels under autophagy-inducing conditions with or without lysosomal inhibitors (Bafilomycin A1, Chloroquine), allowing calculation of autophagic flux. Additional quantification can be performed through immunofluorescence by measuring the number and intensity of YIPF3-positive puncta that colocalize with LC3 and LAMP1 under different experimental conditions.

How do YIPF3 and YIPF4 antibodies help distinguish their differential roles in the Golgiphagy receptor complex?

YIPF3 and YIPF4 antibodies are essential tools for dissecting the differential roles of these proteins in the Golgiphagy receptor complex. While YIPF3 and YIPF4 form a complex together, they have distinct functions: YIPF3 directly interacts with ATG8 family proteins through its LIR motif, while YIPF4 stabilizes YIPF3 without directly binding to ATG8s . Using both antibodies in co-immunoprecipitation experiments reveals that endogenous YIPF3 interacts with FLAG-tagged LC3B, GABARAP, and GABARAPL1, whereas YIPF4 shows no clear interaction with ATG8 proteins . Immunofluorescence studies with both antibodies demonstrate that YIPF3-knockout suppresses YIPF4 levels and vice versa, indicating their interdependence . Western blotting experiments using both antibodies in genetically modified cells (CRISPR/Cas9 knockout or siRNA knockdown of either protein) help quantify their reciprocal effects on protein stability. The mRFP-EGFP-Golgi reporter system, combined with immunostaining for YIPF3 and YIPF4, allows observation of how depletion of either protein affects Golgiphagic activity, revealing similar impairments in both YIPF3-KO and YIPF4-KO cells and suggesting their cooperative function as a complex .

What are common issues when using YIPF3 antibodies and how can they be resolved?

Researchers working with YIPF3 antibodies may encounter several common issues that can be systematically addressed. For weak or absent signals in western blots, optimize protein extraction using specialized membrane protein extraction buffers with appropriate detergents (RIPA or NP-40 with 0.1-0.5% SDS), as YIPF3 is a multi-pass membrane protein that may be difficult to solubilize. Increase antibody concentration (starting from 1:500 dilution) or extend incubation times (overnight at 4°C) if signal remains weak . For high background in immunostaining, implement stringent blocking (5% BSA or 5-10% normal serum from the secondary antibody host species) and include additional washing steps with 0.1% Tween-20 in PBS. Regarding specificity concerns, validate antibodies using YIPF3 knockout or knockdown samples as negative controls. For inconsistent results across experiments, standardize cell culture conditions, as YIPF3 expression and localization may be affected by cell density, stress conditions, and autophagy induction status. If detecting YIPF3 in tissue samples is problematic, optimize antigen retrieval methods (citrate buffer pH 6.0 or EDTA buffer pH 9.0) and extend primary antibody incubation times. For co-immunoprecipitation difficulties, consider using crosslinking reagents to stabilize transient interactions before cell lysis .

How can researchers optimize conditions for studying YIPF3-ATG8 interactions using antibody-based techniques?

Optimizing conditions for studying YIPF3-ATG8 interactions requires careful consideration of several factors. For co-immunoprecipitation experiments, use mild lysis buffers (containing 0.5-1% NP-40 or 0.5% Triton X-100) with protease inhibitors to preserve protein-protein interactions. Consider crosslinking proteins in intact cells using membrane-permeable crosslinkers like DSP (dithiobis(succinimidyl propionate)) before lysis to stabilize transient interactions . When studying endogenous interactions, use higher amounts of starting material (1-2 mg total protein) and optimize antibody amounts for immunoprecipitation (typically 2-5 μg per mg of protein). For enhanced detection of ATG8 family members after immunoprecipitation with YIPF3 antibodies, use highly sensitive detection methods such as enhanced chemiluminescence (ECL) or fluorescent secondary antibodies. To increase specificity, include appropriate negative controls such as IgG isotype controls and YIPF3 knockout/knockdown samples. For studying the effects of starvation or other autophagy inducers on YIPF3-ATG8 interactions, optimize induction conditions (typically 2-4 hours of starvation in EBSS) and consider using Bafilomycin A1 (100-200 nM) to prevent autophagosome-lysosome fusion, potentially enhancing detection of these interactions .

What methodological considerations are important when using YIPF3 antibodies in different cell types and tissues?

When using YIPF3 antibodies across different cell types and tissues, several methodological considerations are crucial for successful experiments. First, verify antibody cross-reactivity for your species of interest, as some YIPF3 antibodies show reactivity to human, mouse, and rat YIPF3, while others may be limited to specific species . For cell types with varying YIPF3 expression levels, adjust antibody concentrations accordingly—cells with lower expression may require higher antibody concentrations or signal amplification methods. When working with primary cells or tissue sections, optimize fixation protocols (typically 4% paraformaldehyde for 10-20 minutes) and permeabilization conditions (0.1-0.3% Triton X-100 for 5-15 minutes), as these may differ from established protocols for cell lines. For tissues, implement appropriate antigen retrieval methods (heat-induced epitope retrieval in citrate buffer pH 6.0 or EDTA buffer pH 9.0) to unmask epitopes that may be obscured during fixation. Consider the subcellular localization pattern of YIPF3, which typically appears as a juxtanuclear Golgi-like structure under normal conditions and forms punctate structures during autophagy induction. This pattern may vary across cell types due to differences in Golgi morphology and autophagy activity . Finally, include appropriate positive controls (cell types known to express YIPF3, such as hematopoietic cells) and negative controls (YIPF3 knockout cells or tissues) to validate staining specificity.

How can YIPF3 antibodies contribute to understanding the relationship between Golgiphagy and neurodegenerative diseases?

YIPF3 antibodies offer significant potential for investigating the relationship between Golgiphagy and neurodegenerative disorders. Neurodegenerative diseases often involve disruptions in protein trafficking, organelle quality control, and autophagy pathways—all processes where YIPF3 plays important roles. Researchers can use YIPF3 antibodies in immunohistochemistry and immunofluorescence studies of brain tissue samples from patients with Alzheimer's, Parkinson's, or Huntington's disease to assess alterations in YIPF3 expression, localization, or post-translational modifications compared to healthy controls. Co-staining with disease-specific markers (such as amyloid-β, α-synuclein, or huntingtin) alongside YIPF3 and autophagy markers can reveal spatial relationships between aggregated proteins and Golgiphagy machinery. In cellular models of neurodegeneration, time-course studies using YIPF3 antibodies can determine whether Golgi fragmentation (a common feature in many neurodegenerative diseases) correlates with changes in YIPF3-mediated Golgiphagy. Additionally, analyzing YIPF3's interaction with ATG8 family proteins in disease models may reveal whether impaired Golgiphagy contributes to pathogenesis. This research direction could potentially identify YIPF3 and Golgiphagy as therapeutic targets for diseases characterized by organelle dysfunction and protein aggregation .

What methods can be used to investigate post-translational modifications of YIPF3 using available antibodies?

Investigating post-translational modifications (PTMs) of YIPF3 requires a multi-faceted approach using available antibodies alongside complementary techniques. Phosphorylation, particularly relevant given YIPF3's putative phosphorylation sites upstream of its LIR motif, can be studied using phospho-specific antibodies if available, or through general phospho-detection after immunoprecipitation with YIPF3 antibodies . Researchers can treat samples with phosphatase inhibitors to preserve phosphorylation states and compare migration patterns on Phos-tag gels, which retard the mobility of phosphorylated proteins, allowing separation of different phosphorylated forms. For ubiquitination studies, perform YIPF3 immunoprecipitation under denaturing conditions (1% SDS with boiling, followed by dilution) to disrupt non-covalent interactions, then immunoblot with anti-ubiquitin antibodies. Mass spectrometry analysis of immunoprecipitated YIPF3 offers a comprehensive approach to identify multiple PTMs simultaneously. To investigate how PTMs affect YIPF3's function in Golgiphagy, combine these analyses with site-directed mutagenesis of key residues (such as serine/threonine sites adjacent to the LIR motif) and assess changes in ATG8 binding and autophagy activity using established reporter systems. Time-course experiments during autophagy induction can reveal dynamic changes in YIPF3 modifications, potentially identifying regulatory mechanisms of Golgiphagy .

How can YIPF3 antibodies be integrated with advanced imaging techniques to study Golgiphagy dynamics?

YIPF3 antibodies can be powerfully integrated with advanced imaging techniques to provide unprecedented insights into Golgiphagy dynamics. For super-resolution microscopy (SIM, STED, or STORM), use highly specific primary YIPF3 antibodies combined with appropriate fluorophore-conjugated secondary antibodies to visualize Golgi fragmentation and YIPF3 redistribution during autophagy with nanoscale resolution (approximately 20-100 nm). This allows precise mapping of YIPF3's spatial relationship with Golgi markers, autophagosome components, and lysosomes beyond the diffraction limit of conventional microscopy. For live-cell imaging, combine YIPF3 antibody fragments (Fab) labeled with cell-permeable fluorophores with fluorescently tagged ATG8 proteins to track their interactions in real-time during Golgiphagy. Lattice light-sheet microscopy offers another powerful approach, enabling volumetric imaging with high spatiotemporal resolution and reduced phototoxicity—ideal for following YIPF3-positive structures over extended periods. Correlative light and electron microscopy (CLEM) allows researchers to first identify YIPF3-positive structures using immunofluorescence, then examine their ultrastructure through electron microscopy, providing multiscale context for Golgiphagy events. Finally, proximity-based techniques such as FRET sensors incorporating YIPF3 or split fluorescent protein complementation systems can monitor protein-protein interactions and conformational changes during Golgiphagy induction, offering mechanistic insights into how the YIPF3-YIPF4 complex recognizes and facilitates Golgi degradation .